Skip to main content

Advertisement

Log in

Is Electron Beam Intraoperative Radiotherapy (ELIOT) Safe in Pregnant Women with Early Breast Cancer? In Vivo Dosimetry to Assess Fetal Dose

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Electron beam intraoperative radiotherapy (ELIOT) is a new technique permitting breast radiotherapy to be completed in a single session. Since ELIOT is associated with much reduced irradiation to nontarget tissues, we carried out a study on nonpregnant breast cancer patients to estimate doses to the uterus during ELIOT to better evaluate the possible use of ELIOT in pregnant breast cancer patients. We performed in vivo dosimetry with thermoluminescence radiation detectors (TLDs) in 15 premenopausal patients receiving ELIOT to the breast (prescribed dose 21 Gy) using two mobile linear accelerators. The TLDs were positioned subdiaphragmatically on the irradiated side, at the medial pubic position, and within the uterus. A shielding apron (2 mm lead equivalent) was placed over the viscera from the subcostal to the subpubic region. TLDs showed mean doses of 3.7 mGy (range 1–8.5 mGy) at subdiaphragm, 0.9 mGy (range 0.3–2 mGy) pubic, and 1.7 mGy (range 0.6–3.2 mGy) in utero, for beam energies in the range 5–9 MeV. These findings indicate that ELIOT with a mobile linear accelerator and shielding apron would be safe for the fetus, as doses of a few mGy are not associated with measurable increased risk of fetal damage, and the threshold dose for deterministic effects is estimated at 100–200 mGy. We conclude that studies on the use of ELIOT in pregnant women treated with conservative breast surgery are justified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Psyrri A, Burtness B. Pregnancy-associated breast cancer. Cancer J. 2005;11:83–95.

    Article  PubMed  Google Scholar 

  2. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7:279–87.

    Article  PubMed  Google Scholar 

  3. Ring AE, Smith IE, Ellis PA. Ann Oncol. Breast cancer and pregnancy. Eur J Surg Oncol. 2005;31:232–36.

    Article  Google Scholar 

  4. Duncan PG, Pope WD, Cohen MM, Greer N. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology. 1986;64:790–4.

    Article  CAS  PubMed  Google Scholar 

  5. Gentilini O, Cremonesi M, Trifiro G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol. 2004;15:1348–51.

    Article  CAS  PubMed  Google Scholar 

  6. Keleher A, Wendt R, Delpassand E, Stachowiak AM, Kuerer HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10:492–5.

    Article  PubMed  Google Scholar 

  7. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6:328–33.

    Article  PubMed  Google Scholar 

  8. Streffer C, Shore R, Konermann G, et al. Biological effects after prenatal irradiation (embryo and foetus). A report of the International Commission on Radiological Protection. Ann ICRP. 2003;33:5–206.

    CAS  PubMed  Google Scholar 

  9. Task Group on Radiation Quality Effects in Radiological Protection, Committee 1 on Radiation Effects, International Commission on Radiological Protection. Relative biological effectiveness (RBE), quality factor (Q), radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection. Ann ICRP. 2003;33:1–117.

    Google Scholar 

  10. International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP. 2000;30:1–43.

    Google Scholar 

  11. Greskovich JF, Macklis RM. Radiation therapy in pregnancy: risk calculation and risk minimization. Semin Oncol. 2000;27:633–45.

    PubMed  Google Scholar 

  12. Antypas C, Sandilos P, Kouvaris J, Balafouta E, Karinou E, Kollaros N, et al. Foetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys. 1998;40:995–9.

    Article  CAS  PubMed  Google Scholar 

  13. Ngu SL, Duval P, Collins C. Foetal radiation dose in radiotherapy for breast cancer. Australas Radiol. 1992;36:321–2.

    Article  CAS  PubMed  Google Scholar 

  14. Antolak JA, Strom EA. Foetal dose estimates for electron-beam treatment to the chest wall of a pregnant patient. Med Phys. 1998;25:2388–91.

    Article  CAS  PubMed  Google Scholar 

  15. Diallo I, Lamon A, Shamsaldin A, Grimaud E, de Vathaire F, Chavaudra J. Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol. 1996;38:269–71.

    Article  CAS  PubMed  Google Scholar 

  16. Van der Giessen PH. Measurement of the peripheral dose for the tangential breast treatment technique with Co-60 gamma radiation and high energy X-rays. Radiother Oncol. 1997;42:257–64.

    Article  PubMed  Google Scholar 

  17. Mazonakis M, Varveris H, Damilakis J, Theoharopoulos N, Gourtsoyiannis N. Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys. 2003;55:386–91.

    Article  PubMed  Google Scholar 

  18. International Commission on Radiological Protection. Biological effects after prenatal irradiation (embryo, foetus). Ann ICRP. 2003;33:205–6.

    Google Scholar 

  19. Loibl S, von Minckwitz G, Gwyn K, et al. Breast carcinoma during pregnancy. International Recommendations from an Expert Meeting. Cancer. 2006;106:237–46.

    Article  PubMed  Google Scholar 

  20. Doll R, Wakeford R. Risk for childhood cancer from foetal irradiation. Br J Radiol. 1997;70:130–9.

    Article  CAS  PubMed  Google Scholar 

  21. Muirhead CR, Cox R, Stather JW, et al. Estimates of late radiation risks to the UK population, Documents of the NRPB 4(4). Chilton: National Radiological Protection Board. 1993;15–157.

  22. United Nations Scientific Committee on the Effects of Atomic Radiation. Ionizing radiation: levels and effects. Report to the General Assembly, with annexes. Vol II. Effects. New York: United Nations; 1972.

  23. Ciocca M, Piazzi V, Lazzari R, et al. Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancer. Radiother Oncol. 2006;78:213–16.

    Article  CAS  PubMed  Google Scholar 

  24. Fenig E, Mishaeli M, Kalish Y, Lishner M. Pregnancy and radiation. Cancer Treat. 2001;Rev 27:1–7.

    Article  Google Scholar 

  25. Orecchia R, Ciocca M, Tosi G, Franzetti S, Luini A, Gatti G, et al. Intraoperative electron beam radiotherapy (ELIOT) to the breast: a need for a quality assurance programme. Breast. 2005;14:541–56.

    Article  CAS  PubMed  Google Scholar 

  26. Veronesi U, Orecchia R, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg. 2005;242:101–6.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Devi PU, Baskar R, Hande MP. Effect of exposure to low-dose gamma radiation during late organogenesis in the mouse foetus. Radiat Res. 1994;138:133–38.

    Article  CAS  PubMed  Google Scholar 

  28. Gilman EA, Kneale GW, Know EG. Pregnancy X-rays and childhood cancer: effects of exposure and radiation dose. J Radiol Prot. 1988;8:3–8.

    Article  CAS  Google Scholar 

  29. Nuyttens JJ, Prado KL, Jenrette JM, Williams TE. Foetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother. 2002;6:352–7.

    Article  CAS  PubMed  Google Scholar 

  30. Mole RH. Childhood cancer after prenatal exposure to diagnostic X-ray examination in Britain. Br J Cancer. 1990;62:152–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Nakagawa K, Aoki Y, Kusama T, Ban N, Nakagawa S, Sasaki Y. Radiotherapy during pregnancy: effects on fetuses and neonates. Clin Therap. 1997;19:770–7.

    Article  CAS  Google Scholar 

  32. Vidal-Pergola GM, Kimler BF, Norton S. Effect of in utero radiation dose fractionation on rat postnatal development: dose fractionation with a 6-h interval. Radiat Res. 1993;134:369–74.

    Article  CAS  PubMed  Google Scholar 

  33. International Commission on Radiological Protection. Biological effects after prenatal irradiation (embryo and fetus). Ann ICPR. 2002;69:36–8.

    Google Scholar 

  34. Rondi E, Ciocca M, Galimberti V, et al. Evaluation of dose to uterus in electron beam IORT for early-stage breast cancer. Radiother Oncol. 81 Suppl 1:S510 (abstract)2006.

  35. Woo SY, Fuller LM, Cundiff JH, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 1992;23:407–12.

    Article  CAS  PubMed  Google Scholar 

  36. Whelan T, Olivotto I, Levine M. For the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Brest cancer. 6. breast radiotherapy after breast-conserving surgery (2003 update). CMAJ. 2003;168:437–9.

    PubMed  PubMed Central  Google Scholar 

  37. Vujovic O, Yu E, Cherian A, Dar AR, Stitt L, Perera F. Eleven-year follow-up results in the delay of breast irradiation after conservative breast surgery in node-negative breast cancer patients. Int J Radiat Oncol Biol Phys. 2006;64:760–4

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. G. Raimondi (Ospedale Maggiore Policlinico, Milan, Italy) for technical assistance with the TLD dosimetry, the Associazione Italiana per la Ricerca sul Cancro (AIRC), and the American Cancer Foundation (AICF) for providing support, and Don Ward for help with English.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Viviana Galimberti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galimberti, V., Ciocca, M., Leonardi, M.C. et al. Is Electron Beam Intraoperative Radiotherapy (ELIOT) Safe in Pregnant Women with Early Breast Cancer? In Vivo Dosimetry to Assess Fetal Dose. Ann Surg Oncol 16, 100–105 (2009). https://doi.org/10.1245/s10434-008-0172-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0172-z

Keywords

Navigation